Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Daratumumab
The First People's Hospital of Lianyungang
Antibody-mediated Rejection
1 trial -
Dexmedetomidine Injection
The First People's Hospital of Lianyungang
Coronary Disease
1 trial -
Dexmedetomidine Injection (nasal spray) + Propofol Injection + Sufentanil Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dexmedetomidine Induced Sedation
1 trial -
Dexmedetomidine injection
United Therapeutics Europe Ltd
Delirium in Old Age
1 trial -
Dexmedetomidine ropivacaine
The First People's Hospital of Lianyungang
Pharmacological Action
1 trial -
Dietary intervention + Physical Activity + Monitoring
NORTHWEST BIOTHERAPEUTICS INC
Gestational Diabetes
1 trial -
Drug treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prolactinoma
1 trial -
EAA
United Therapeutics Europe Ltd
Military Operational Stress Reaction
1 trial -
EVM18001 Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
System Lupus Erythematosus(SLE)
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Postoperative Cognitive Dysfunction
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Post Induction Hypotension
1 trial -
Esketamine, Sulfentanil or/and Remifentanil
Second Affiliated Hospital of Soochow University
Opioid Analgesic Adverse Reaction
1 trial -
ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules
Biotech Pharmaceutical Co.,
Cognitive Functions Perceptual Disturbances
1 trial -
FAST Technique
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ST-Segment Elevation Myocardial Infarction
1 trial -
Facility HIVST
United Therapeutics Europe Ltd
HIV Infections
1 trial -
Fei Re Qing Granules
The First People's Hospital of Lianyungang
Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection
1 trial -
Fluorometholone
Hospital Authority, Hong Kong
Pterygium of the Conjunctiva and Cornea
1 trial -
Folic acid
CRESCENT BIOPHARMA, INC.
Acute Myocardial Infarction
1 trial -
Follitropin Beta;MSD
Reproductive & Genetic Hospital of CITIC-Xiangya
Infertility
1 trial -
Forced administration of furosemide
The First People's Hospital of Lianyungang
Cytoreductive Surgery
1 trial -
GDMT
The First People's Hospital of Lianyungang
Heart Failure With Preserved Ejection Fraction
1 trial -
Galantamine
BRIGHT MINDS BIOSCIENCES INC.
Addiction
1 trial -
Gastrodin Injection
The First People's Hospital of Lianyungang
Sensorineural Hearing Loss
1 trial -
Gene detection of therapeutic drugs for chronic cardiovascular and cerebrovascular diseases
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension,Essential
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources